Related Experiment Video
Updated: May 22, 2026

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Vitamin K status in patients with short bowel syndrome
Patrycja Krzyżanowska1, Janusz Książyk, Małgorzata Kocielińska-Kłos
1Department of Gastroenterology and Metabolism, Poznan University of Medical Sciences, Poznan, Poland.
Insights
Short bowel syndrome (SBS) patients may face vitamin K deficiency, impacting their health. This study assessed vitamin K status in SBS patients, finding potential deficiencies in some.
Area of Science:
- Pediatric Gastroenterology
- Nutritional Science
- Hepatology
Background:
- Short bowel syndrome (SBS) is associated with malabsorption of fat-soluble vitamins.
- While deficiencies in vitamins A, D, E, and B1 are recognized, vitamin K status in SBS patients remains under-investigated.
Purpose of the Study:
- To evaluate the body's vitamin K reserves in a cohort of pediatric patients with short bowel syndrome.
- To identify the prevalence of vitamin K deficiency in this vulnerable population.
Main Methods:
- The study included 33 patients diagnosed with SBS, ranging in age from 1 month to 16 years.
- Vitamin K status was assessed by measuring plasma concentrations of PIVKA-II (protein induced by vitamin K absence or antagonist-II).
Main Results:
- All patients exhibited normal coagulation parameters.
- PIVKA-II levels indicating vitamin K deficiency were detected in 9.1% of the SBS patients.
- Patients with cirrhosis and cholestasis had low PIVKA-II levels, but received regular vitamin K supplementation.
Conclusions:
- Vitamin K deficiency is a potential complication in patients with short bowel syndrome.
- Regular monitoring of vitamin K status is recommended for SBS patients, particularly those with liver complications.
Background & Aims:
Available evidence suggests that patients with short bowel syndrome (SBS) might be at risk of vitamins A, D, E and B(1) deficiency. However, there is little clinical data describing the vitamin K status. Therefore, in the present study we aimed to assess the body resources of vitamin K in a subset of SBS patients.
Methods:
The study comprised 33 patients aged 1 month to 16 years. PIVKA-II concentrations were determined in all subjects.
Results:
In all studied subjects, coagulation parameters were normal. PIVKA-II levels indicative of vitamin K deficiency was found in 3 (9.1%) SBS patients. One patient had been receiving an additional intravenous vitamin K dose of 5 mg/week. In all SBS patients with cirrhosis and cholestasis, PIVKA-II concentrations were low (<2 ng/ml). However, all patients with severe liver disease were receiving vitamin K several times a month.
Conclusions:
Vitamin K deficiency may appear in SBS patients.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Vitamins
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Chronic Kidney Disease III: Interprofessional Care
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
